S100A16 induces epithelial-mesenchymal transition in human PDAC cells and is a new therapeutic target for pancreatic cancer treatment that synergizes with gemcitabine
Ting Li, Tianyi Ren, Chumei Huang, Yufang Li, Pengfei Yang, Gang Che, Lisi Luo, Yutong Chen, Siqi Peng, Yujing Lin, Linjuan Zeng
Topics & Concepts
Cancer researchGemcitabineEpithelial–mesenchymal transitionPancreatic cancerDownregulation and upregulationMetastasisBiologyCancerGeneInternal medicineMedicineGeneticsS100 Proteins and AnnexinsPancreatic and Hepatic Oncology ResearchBiomarkers in Disease Mechanisms